SARS-CoV-2 infection after alemtuzumab in a multiple sclerosis patient: milder disease symptoms in comparison with coinfected relatives: a case report and review of the literature

Literature data reporting SARS-CoV-2 infection in multiple sclerosis (MS) patients recently treated with immunodepleting agents as cladribine and alemtuzumab are very limited. The relationship between iatrogenic immunodeficiency and risk related to SARS-CoV-2 infection and its severe complications i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraceno, Lorenzo, Susani, Emanuela Laura, Marazzi, Maria Raffaella, Moioli, Maria Cristina, Agostoni, Elio Clemente, Protti, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384460/
https://www.ncbi.nlm.nih.gov/pubmed/34431013
http://dx.doi.org/10.1007/s10072-021-05567-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384460/
https://www.ncbi.nlm.nih.gov/pubmed/34431013
http://dx.doi.org/10.1007/s10072-021-05567-7

Ejemplares similares